Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Storek

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Blood|November 23, 2000
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipientsG Mathioudakis, R Storb, P A McSweeney, et al.
Bone Marrow Transplantation|February 3, 2015
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxisA B M Lim, J Storek, A Beligaswatte, et al.
Blood|December 12, 2001
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantationJ Storek, A Joseph, G Espino, et al.
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Leukemia|July 30, 2011
High Epstein-Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantationM Hoegh-Petersen, S Sy, A Ugarte-Torres, et al.
Bone Marrow Transplantation|January 28, 2014
Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal functionC D Griffiths, E S M Ng, S B Kangarloo, et al.
Bone Marrow Transplantation|November 21, 2012
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHDL M Pratt, Y Liu, A Ugarte-Torres, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allograftsL C Feinstein, K Seidel, J Jocum, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Blood|November 23, 2000
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipientsG Mathioudakis, R Storb, P A McSweeney, et al.
Bone Marrow Transplantation|February 3, 2015
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxisA B M Lim, J Storek, A Beligaswatte, et al.
Blood|December 12, 2001
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantationJ Storek, A Joseph, G Espino, et al.
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Leukemia|July 30, 2011
High Epstein-Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantationM Hoegh-Petersen, S Sy, A Ugarte-Torres, et al.
Bone Marrow Transplantation|January 28, 2014
Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal functionC D Griffiths, E S M Ng, S B Kangarloo, et al.
Bone Marrow Transplantation|November 21, 2012
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHDL M Pratt, Y Liu, A Ugarte-Torres, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allograftsL C Feinstein, K Seidel, J Jocum, et al.
Pageof 8